20/20 Biolabs, Inc. (AIDX)
0.8669
-0.08
(-8.75%)
USD |
NASDAQ |
May 29, 16:00
0.879
+0.01
(+1.40%)
After-Hours: 20:00
20/20 Biolabs EPS Diluted (Quarterly) : -0.2031 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Sanara MedTech, Inc. | 0.0511 |
| Intelligent Bio Solutions, Inc. | -1.795 |
| Anteris Technologies Global Corp. | -0.2774 |
| FONAR Corp. | 0.2441 |
| Quest Diagnostics, Inc. | 2.241 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.175M |
| Revenue (Quarterly) | 0.3534M |
| Total Expenses (Quarterly) | 2.528M |
| Enterprise Value | 6.110M |
| Gross Profit Margin (Quarterly) | 17.80% |
| Profit Margin (Quarterly) | -615.4% |
| Earnings Yield | -87.47% |